临床ClotPro血栓显微镜测定出血风险在两个猫的XII因子缺乏症
Vera Forer1, Pavlos G Doulidis1, Verena Steiner2
1Clinical Center for Small Animals, Division of Small Animal Internal Medicine, Department for Small Animals and Horses, University of Veterinary Medicine, Vienna, Austria.
JFMS open reports
|April 2, 2025
概括
猫的XII因子 (FXII) 缺乏会导致凝血时间延长,但不会增加出血风险. 这项研究强调了ClotPro系统用于诊断猫类动物的FXII缺乏症.
科学领域:
- 兽医血液学 兽医血液学
- 凝血障碍 凝血障碍 凝血障碍
- 猫科动物遗传学
背景情况:
- 十二因子 (FXII) 缺乏症是猫的一种罕见的自体相衰退性遗传疾病.
- 它的特点是长时间的激活部分血栓形成时间 (aPTT),没有显著的出血风险.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
570
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
570
Clot Retraction and Fibrinolysis
3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K


